2013-09-09 | Downgrade | Dougherty & Company | Buy to Neutral | |
2013-03-21 | Initiated | Dougherty & Company | Buy | $12.50 |
2012-09-24 | Upgrade | Oppenheimer | Perform to Outperform | $19 |
2012-06-19 | Downgrade | Robert W. Baird | Outperform to Neutral | $25 to $9 |
2012-06-19 | Downgrade | Oppenheimer | Outperform to Perform | |
2012-05-09 | Reiterated | Avondale | Mkt Perform | $24 to $17 |
2012-05-01 | Reiterated | Avondale | Mkt Perform | $34 to $37 |
2011-12-21 | Reiterated | Avondale | Mkt Outperform | $26 to $30 |
2011-04-19 | Initiated | Avondale | Mkt Outperform | $30 |
2011-03-25 | Reiterated | Oppenheimer | Outperform | $20 to $25 |
2011-03-22 | Initiated | Oppenheimer | Outperform | $20 |
2013-09-09 | Downgrade | Dougherty & Company | Buy to Neutral | |
2013-03-21 | Initiated | Dougherty & Company | Buy | $12.50 |
2012-09-24 | Upgrade | Oppenheimer | Perform to Outperform | $19 |
2012-06-19 | Downgrade | Robert W. Baird | Outperform to Neutral | $25 to $9 |
2012-06-19 | Downgrade | Oppenheimer | Outperform to Perform |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In BODY 0 funds of 2213 total. Show all
Fund name | Ticker shares |
---|
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Rosenbaum Jerrold | 1.20% (206742) | BODY / |
Angelo Beth EVP & Chief Merchandising Ofcr | 0.50% (86777) | BODY / |
DOOLAN MARTIN P | 0.26% (44912) | BODY / |
ECTON DONNA R | 0.18% (30457) | BODY / KAR / UAN / |
GLASS ROBERT | 0.16% (27469) | BODY / |
KATZ DAVID A. | 0.14% (24651) | BODY / |
Stoltz Thomas W Chief Financial Officer | 0.13% (22471) | BODY / |
Weinstein Allen President & CEO | 0.12% (20972) | BODY / DEST / |
Gallin Scott | 0.12% (20355) | BODY / |
Salopek Jennifer C | 0.10% (16661) | BODY / |
Haley John K | 0.08% (14122) | BODY / GGP / |
SWARTWOOD MATTHEW Senior Vice President, Sales | 0.05% (7972) | BODY / |
Simigran Patti SVP, GMM | 0.02% (3704) | BODY / |